Serotonin syndrome and the anaesthetist

Anaesthesia and Intensive Care

Volumn 33, Issue 2, 2005, Pages 181-187

  Jones, D ^a,b   Story, D A ^a,b  

^a AUSTIN HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Syndrome, Serotonin: serotonin uptake inhibitors, tramadol, 5 hydroxytryptamine, rhabdomyolysis, cyproheptadine

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMITRIPTYLINE; AMPHETAMINE DERIVATIVE; BROMOCRIPTINE; CHLORPROMAZINE; COCAINE; CYPROHEPTADINE; DIAZEPAM; FLUOXETINE; HYPERTENSIVE AGENT; IMIPRAMINE; KETANSERIN; LEVODOPA; METHYSERGIDE; MIDAZOLAM; MONOAMINE OXIDASE INHIBITOR; MUSCLE RELAXANT AGENT; OLANZAPINE; PAROXETINE; PETHIDINE; PROPRANOLOL; RECREATIONAL DRUG; SELEGILINE; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUMATRIPTAN; TRAMADOL; UNINDEXED DRUG;

ANTICHOLINERGIC EFFECT; ARTIFICIAL VENTILATION; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG MECHANISM; DRUG OVERDOSE; DRUG POTENTIATION; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; INCIDENCE; INTENSIVE CARE; MONOTHERAPY; NERVOUS SYSTEM; NEUROMUSCULAR DISEASE; NEUROMUSCULAR FUNCTION; PRESCRIPTION; REVIEW; RHABDOMYOLYSIS; SEROTONIN SYNDROME; SIDE EFFECT; SYMPTOMATOLOGY; TACHYCARDIA; THROMBOCYTE MEMBRANE; VALIDATION PROCESS; VASCULAR ENDOTHELIUM;

EID: 17144421599     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0503300205     Document Type: Review

References (44)

1. Sternbach H. Serotonin syndrome: How to avoid, identify, and treat dangerous drug interactions, Current Pyschiatry Online. Available at http://www.currentpsychiatry.com/2003_05/0503_serotonin. Accessed 25 May 2004.
2. Mackay FJ, Dunn RN, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999; 49:871-874.
3. Therapeutic Goods Administration. Tramadol - four years' experience. Aust Adverse Drug React Bull 2003; 22:1.
4. Parker GB. Depressed Australians: should we worry? Med J Aust 2000; 173:453-455.
5. Sweeny K. Trends in the use and cost of pharmaceuticals under the pharmaceutical benefits scheme.
6. Hall M. Serotonin syndrome. Australian Prescriber 2003; 26:62-63.
7. McManus P, Mant A, Mitchell PB et al. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust 2000; 173:458-461.
8. Ener RA, Meglathery SB, Van Decker WA, Gallagher RM. Serotonin syndrome and other serotonergic disorders. Pain Med 2003; 4:63-74.
9. Glennon RA, Dukat M, Westkaemper RB. Serotonin receptor subtypes and ligands. In Psychopharmacology - The Fourth Generation of Progress. Available at http://www.acnp.org/g4/GN401000039/Ch039.html Accessed 5 Nov 2004.
10. Mills KC. Serotonin syndrome. A clinical update. Crit Care Clin 1997; 13:763-783.
11. Shih JC, Chen KJ-S, Gallagher TK. Molecular Biology of Serotonin Receptors. In Psychopharmacology - The Fourth Generation of Progress. Available at http://www.acnp.org/g4/GN401000038/CH038.html Accessed 5 Nov 2004.
12. Murphy DL. An Overview of Serotonin Neurochemistry and Neuroanatomy. In 5-hydroxytryptamine in psychiatry. A spectrum of ideas. eds. Sandler M, Coppen A, Harnett S. Oxford Medical Publications. Oxford University Press 1991. pp 23-36.
13. Saper CB. Brain stem modulation of sensation, movement, and consciousness. In Principles of Neural Science 4th edition. eds. Kandel ER, Schwartz JH, and Jessel TM. McGraw-Hill 2000. pp 889-909.
14. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet 1998; 352:799-805.
15. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13:100-109.
16. Brown TM., Skop BP, Mareth TR. Pathophysiology and management of the serotonin syndrome. Ann Pharmacother 1996; 30:527-533.
17. Martin TG. Serotonin syndrome. Ann Emerg Med 1996; 28: 520-526.
18. Chan BS, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG. Serotonin syndrome resulting from drug interactions. Med J Aust 1998; 169; 523-525.
19. Egermayer P, Town GI, Peacock AJ. Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax 1999; 54:161-168.
20. Garrett PM. Tramadol overdose and serotonin syndrome manifesting as acute right heart dysfunction. Anaesth Intensive Care 2004; 32:575-577.
21. Bernard L, Stern R, Lew D, Hoffmeyer P. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis 2003; 36:1197.
22. Bilbao Garay J, Mesa Plaza N, Castilla Castellano V, Dhimes Tejada P. Serotonin syndrome: report of a fatal case and review of the literature. Rev Clin Esp 2002; 202:209-211.
23. Dams R, Benijts TH, Lambert WE et al. A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication. J of Anal Toxicol 2001; 25:147-151.
24. Hernandez JL, Ramos FJ, Infante J et al Severe serotonin syndrome induced by mirtazapine monotherapy. Ann Pharmacother 2002; 26:641-643.
25. Miller F, Friedman R, Tanenbaum J, Griffin A. Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonin syndrome. J Clin Psychopharmacol 1991; 11:277-279.
26. Sandyk R. L-dopa induced "serotonin syndrome" in a Parkinsonian patient on bromocriptine. J Clin Psychopharmacol 1986; 6:194-195.
27. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997; 17:208-221.
28. Haslett CD, Kumar S. Can olanzapine be implicated in causing serotonin syndrome? Psychiatry Clin Neurosci 2002; 56:533-535.
29. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148:705-713.
30. Wappler F. Malignant hyperthermia. Eur J Anaesthesiol 2001; 18:632-652.
31. Birmes P, Coppin D, Schmitt L, Laugue D. Serotonin syndrome: a brief review. CMAJ 2003; 168:1439-1442.
32. Garside S, Rosebush PI. Serotonin syndrome: not a benign toxidrome. CMAJ 2003; 169:543.
33. Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth 2000; 85:129-135.
34. Frommer DA, Kulig KW, Marx JA, Rumack B. Tricyclic antidepressant overdose. A review. JAMA 1987; 257:521-526.
35. Kokan L. Monoamine Oxidase Inhibitors. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. Goldfrank's Toxicologic Emergencies, 7th Ed. McGraw-Hill, New York, 2002, pp. 885-889.
36. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine, 15th Ed, McGraw-Hill, New York, 2001; pp. 763-1167.
37. Mills KC. Serotonin Syndrome. Am Fam Physician 1995; 52:1475-1482.
38. Gillman PK. Successful treatment of the serotonin syndrome with chlorpromazine. Med J Aust 1996; 165:345-346.
39. Lappin RI, Auchincloss EL. Treatment of serotonin syndrome with cyproheptadine. N Engl J Med 1994; 331:1021-1022.
40. Thomson Micromedex. Serotonin Syndrome. Micromedex Health Care Series. Available at: http://www.antidepressants-facts.com/micromedex-serotonin-syndrome.htm. Accessed 25 May 2004.
41. Baigel GD. Cyproheptadine and the treatment of an unconscious patient with serotonin syndrome: Eur J Anaesthesiol 2003; 20:586-588.
42. Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16:615-619.
43. McDaniel WW. Serotonin syndrome: early management with cyproheptadine. Ann Pharmacother 2001; 35:870-873.
44. Houghton Y, Carter JA. Peri-operative management of carcinoid syndrome using ketanserin. Anaesthesia 1986; 41:596-599.